BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29689304)

  • 1. Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
    Chinello C; Stella M; Piga I; Smith AJ; Bovo G; Varallo M; Ivanova M; Denti V; Grasso M; Grasso A; Del Puppo M; Zaravinos A; Magni F
    J Proteomics; 2019 Jan; 191():29-37. PubMed ID: 29689304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model.
    Liu X; Zhang M; Shao C; Sun H; Zhang B; Guo Z; Sun J; Qi F; Zhang Y; Niu H; Sun W
    Mol Cell Proteomics; 2023 Aug; 22(8):100603. PubMed ID: 37348606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
    J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
    Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
    Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH
    Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.
    Yokomizo A; Takakura M; Kanai Y; Sakuma T; Matsubara J; Honda K; Naito S; Yamada T; Ono M
    Cancer Biomark; 2011-2012; 10(3-4):175-83. PubMed ID: 22674303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.
    Jamal M; Taneja K; Arora S; Barod R; Rogers CG; Sanchez J; Gupta NS; Williamson SR
    Int J Surg Pathol; 2018 Sep; 26(6):536-541. PubMed ID: 29560759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J; Liu P; Tian M; Li Y; Chen W; Li X
    Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma.
    Shah PH; Lyon TD; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA; Thompson RH
    BJU Int; 2019 Feb; 123(2):270-276. PubMed ID: 30113768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrograde venous invasion in renal cell carcinoma: a complication of sinus vein and main renal vein invasion.
    Bonsib SM; Bhalodia A
    Mod Pathol; 2011 Dec; 24(12):1578-85. PubMed ID: 21822202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary analysis of differentially expressed proteins of clear-cell renal cell carcinoma by comparative proteomic technologies].
    Yang J; Li X; Tian MJ; Wang LN; Cheng TT; Chen W
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):571-6. PubMed ID: 23158988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.
    Raimondo F; Corbetta S; Savoia A; Chinello C; Cazzaniga M; Rocco F; Bosari S; Grasso M; Bovo G; Magni F; Pitto M
    Mol Biosyst; 2015 Jun; 11(6):1708-16. PubMed ID: 25926002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
    Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
    Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid.
    Minamida S; Iwamura M; Kodera Y; Kawashima Y; Tabata K; Matsumoto K; Fujita T; Satoh T; Maeda T; Baba S
    Anal Bioanal Chem; 2011 Jul; 401(1):245-52. PubMed ID: 21553213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
    Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
    Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA.
    Nizioł J; Bonifay V; Ossoliński K; Ossoliński T; Ossolińska A; Sunner J; Beech I; Arendowski A; Ruman T
    Anal Bioanal Chem; 2018 Jun; 410(16):3859-3869. PubMed ID: 29658093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.
    Rodriguez Faba O; Linares E; Tilki D; Capitanio U; Evans CP; Montorsi F; Martínez-Salamanca JI; Libertino J; Gontero P; Palou J
    Eur Urol Focus; 2018 Apr; 4(3):435-441. PubMed ID: 28753848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
    Zhao Z; Wu F; Ding S; Sun L; Liu Z; Ding K; Lu J
    Tumour Biol; 2015 Feb; 36(2):939-51. PubMed ID: 25315187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.